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Recognised by their de novo expression of alpha-smooth muscle actin (SMA), recruitment of myoﬁbroblasts is key to the
pathogenesis of ﬁbrosis in chronic kidney disease. Increasingly, we realise that epithelial-mesenchymal transition (EMT) may
be an important source of these cells. In this study we describe a novel model of renal EMT. Rat kidney explants were ﬁnely
diced on gelatin-coated Petri dishes and cultured in serum-supplemented media. Morphology and immunocytochemistry were
used to identify mesenchymal (vimentin+, α-smooth muscle actin (SMA)+, desmin+), epithelial (cytokeratin+), and endothelial
(RECA+) cells at various time points. Cell outgrowths were all epithelial in origin (cytokeratin+) at day 3. By day 10, 50±12%
(mean±SE) of cytokeratin+ cells double-labelled for SMA, indicating EMT. Lectin staining established a proximal tubule origin.
Byday17,culturesconsistedonlyofmyoﬁbroblasts(SMA+/cytokeratin−).ExplantingisareproducibleexvivomodelofEMT.The
abilitytomodifythischange inphenotypeprovides ausefultoolto studytheregulation and mechanisms ofrenal tubulointerstitial
ﬁbrosis.
1.Introduction
Over recent years, considerable clinical and laboratory work
has focused on the role of tubulointerstitial pathology in
progressive renal disease and the cellular basis of its patho-
genesis [1, 2].
Many of these studies have now indicated that interstitial
ﬁbroblasts are a major determinant of progression of all hu-
man and experimental models of end-stage renal disease.
Fibroblasts can be stimulated by a wide variety of agents de-
rived from stimulated tubular cells, leukocytes, or from the
ﬁbroblasts themselves. Activated ﬁbroblasts, the so-called
myoﬁbroblasts, are usually recognized by their de novo
expression of alpha-smooth muscle actin (SMA), a protein
usually only found in vascular smooth muscle cells [3, 4].
Fibroblasts are fundamentally important to the pathogenesis
of tubulointerstitial ﬁbrosis, with animal studies showing
that incorporation of a suicide transgene can conditionally
minimise ﬁbrogenesis through depletion of ﬁbroblasts [5].
It is in turn increasingly recognised that myoﬁbroblasts
may be derived from a number of sources, including resident
ﬁbroblasts,migrating perivascular(adventitial cells),recruit-
ment of circulating progenitor cells, and injured tubular
cells through a process of epithelial mesenchymal transition
(EMT). EMT can be deﬁned as the acquisition of phenotypic
as well as functional properties of mesenchymal cells by
epithelial cells [6]. In this process, epithelial cells lose their
phenotypic markers and characteristics and migrate into the
surrounding matrix where they acquire phenotypic charac-
teristics typical of mesenchymal cells. In vivo models have
shown that EMT is an orchestrated sequence of events
which relies not only on an interplay of diﬀerent cytokine
and noncytokine mediators but also on the integrity of the
tubular epithelial cell, its intact basement membrane and cell
adhesive proteins, and the nearby interstitium [7]. The re-
peated observation of EMT in both human renal biopsies [8]
and animal models [9] has suggested that tubular epithelial2 Journal of Biomedicine and Biotechnology
Table 1: Cytochemical markers of renal cell phenotype.
Antigen Supplier Clone Source Speciﬁcity
Vimentin Dako V9 Mouse Mesenchymal cells
αSMA Dako 1A4 Mouse Smooth muscle cells, myoﬁbroblasts, mesangial cells
αSMA (Cy3 conjugate) Sigma IA4 Mouse Smooth muscle cells, myoﬁbroblasts, mesangial cells
Desmin Dako D33 Mouse Myoﬁbroblasts, smooth muscle cells, glomerular podocytes
Cytokeratin Dako LP34 Mouse Epithelial cells
RECA Serotec HIS 52 Mouse Endothelial cells
E-cadherin BD Biosciences 36 Mouse Epithelial cells
cells are a major source of interstitial myoﬁbroblasts in the
kidney. Indeed, elegant experiments from Iwano et al. [7]
have shown that after unilateral ureteric obstruction (UUO)
approximately40%ofﬁbroblastsarederivedfromEMT.This
suggests that a process that was once thought to be conﬁned
to embryogenesis may in hindsight be a fundamentally
important process in the pathogenesis of renal scarring.
However, the role of EMT in renal ﬁbrosis is not without
controversy [10], which has recently culminated in back-
to-back editorial debate [11]. Recent lineage tracing studies
from Humphreys and colleagues [12] have shown that per-
icytes, not tubule cells, are the predominant source of
ﬁbroblasts in UUO.
Consequently, the study of renal tubulointerstitial ﬁbro-
sis requires robust experimental models that accurately
reproduce EMT in experimental conditions. While most in
vivo models have proven invaluable to delineating mech-
anisms of EMT, the kinetics of EMT has limited their
usefulness.Inreality,fewcellsundergothisprocessatanyone
time in vivo. Likewise, although EMT can be readily induced
in vitro, this is at least in one case quite diﬀerent from what
happens to the same cells in vivo [12]. Furthermore, the
complexity of EMT and its dependence on other cellular
programmes [13] and the microenvironment [14] raises
important questions about the usefulness of isolated cell
lines.
In this paper we describe the characterisation and vali-
dation of a new ex vivo model of EMT. It is our contention
thatthisprovidesanaccurateandreproduciblemodelforthe
study of this important process.
2.MaterialsandMethods
2.1. Ex Vivo Culture of Renal Explants. EMT was studied
using cell explant outgrowths from normal rat kidneys using
explanting methods described previously [15]. Renal cortex
for explants was excised from Sprague-Dawley rats asphyxi-
ated with an 80%:20% mixture of CO2 :O 2.T i s s u ew a sc o l -
lected in ice-cold Hanks’ salt solution with gentamycin (MP
Biomedicals, Solon, Ohio, USA). Cultures were established
by dicing cortical tissue onto gelatin- (Sigma, St. Louis, Mo,
USA) coated Petri dishes and covering with DMEM (CSL,
Parkville, Vic, Australia) supplemented with 20% foetal calf
serum (FCS; CSL) and Penicillin/Streptomycin antibiotics
(ICN). Tissue was maintained at 37◦C overnight with fur-
ther medium supplementation the following day. Explant
outgrowths were then cultured for 3–17 days, with medium
changed every third day. In each case cells were ﬁxed by
ﬂooding Petri dishes with ice-cold methanol for 10min.
2.2. Cell Phenotype. Cell outgrowths were phenotyped
by immunocytochemistry, using standard techniques [16].
Fixed cells were consecutively incubated with primary antis-
era against cell-speciﬁc proteins using vimentin, SMA, pan-
cytokeratin (all Dako, Glostrup, Denmark), rat endothelial
cellantigen(RECA;Serotec,Oxford,UK),orE-cadherin(BD
Biosciences Pharmingen, San Jose, Calif, USA) (Table 1).
Explants were then rinsed in PBS, incubated with appropri-
ate species-speciﬁc biotinylated secondary antisera (Vector
Laboratories, Burlingame, Calif, USA), washed in PBS, and
incubated with avidin-biotin complex (ABC; Vector) and
diaminobenzidine (DAB; Dako). DAB enhancing solution
(Vector) was used to enhance the reaction product, and
cells were then counterstained with Harris haematoxylin and
mounted with Gurr Aquamount (BDH, Poole, UK). Cells
with positive staining were enumerated and expressed as a
percentage of total cells counted.
2.3. Double Labelling of Epithelial and Mesenchymal Cells.
In the case of double labelling, cells were prepared, treated,
and ﬁxed as above. Cells were then washed in PBS, blocked
with normal serum, and incubated with a murine antibody
against anticytokeratin. An anti-mouse FITC (Dako) was
then applied followed by an anti-SMA Cy3 conjugate (Sig-
ma).Cellsweremountedinaqueousmountingmedia(Dako)
and viewed with a ﬂuorescent microscope (Leica Microsys-
tems, Wetzlar, Germany) using appropriate ﬁlters for 520nm
(FITC) and 570nm (Cy3) emissions. Representative images
at the two diﬀerent wavelengths were captured with a digital
microscope camera (DP10, Olympus, Tokyo, Japan) and
merged using the combine function in PaintShop Pro (Jasc
Software, Minnetonka, Mich, USA).
2.4. Lectin Staining. Explant outgrowths were stained with
lectins to determine the origin of the epithelial cell out-
growths. This methodology has been used previously in a
number of studies to identify epithelial tubular segments
[17–19].
Speciﬁcity of lectin binding was ﬁrst conﬁrmed by stain-
ing normal paraﬃn-embedded kidney tissue sections. Tissue
sections were incubated for 2hr with biotin-conjugated
phaseolus vulgaris leukoagglutinin (Pha-L; Vector) (proximalJournal of Biomedicine and Biotechnology 3
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Figure 1: Phase contrast light microscopy of tissue at 3, 10, and 17 days after explanting. (a) Cuboidal-shaped cells are clearly seen
propagating from explanted tissue at day 3. (b) By day 10 cells at the periphery have a more elongated morphology (arrows). (c) At day
17, conﬂuent areas of cells form ﬁngerprint patterns, characteristic of ﬁbroblast culture. Diagonal line shows scratch in Petri dish used to
mince tissue and anchor tissue to culture surface. Scale bar = 25μm.
tubules and thick loop of Henle), phaseolus vulgaris eryth-
roagglutinin (Pha-E; Vector) (proximal tubules), Bandeiraea
simplicifolia I (BSL-I; Sigma) (collecting ducts, vasa recta),
or Arachis hypogaea (Sigma) (distal convoluted tubules and
collecting ducts). This was followed by incubation with ABC
and DAB. Finally, tissue sections were dehydrated, counter-
stained with Harris haematoxylin, and mounted with Gurr
Aquamount.
Likewise, to characterise explant outgrowths, explants
were ﬁxed in methanol at day 10, washed in PBS, and in-
cubated with Pha-L, BSL-I, or AH conjugates before being
treated as above.
2.5. Statistical Analysis. Data is represented as mean ± SE.
3. Results
The basis for presenting this ex vivo model of EMT lies in
the typical growth patterns that have been observed during
explanting of the renal cortex. Once cortical renal tissue is
mincedintogelatin-coatedPetridishes,ittakesapproximate-
ly 3 days before cell growth can be identiﬁed. Of those cells
that grow out initially, most are cuboidal in shape (Figure
1(a)). Typical of epithelial cell culture, they grew in a uni-
form manner consistent with being tightly bound by cell-cell
junctions and adhesions [20]. In contrast with this epithelial
cell-like phenotype, from day 10, cells at the periphery of
this outgrowth had a spindle shape appearance and were less
organized in the surrounding matrix (Figure 1(b)). This was
more consistent with a mesenchymal phenotype, their non-
uniformity and weak cellular adhesion sites being indicative
of a migratory capacity [20]. Cells proliferated rapidly over
the next 1-2 weeks until most regions became conﬂuent
(Figure 1(c)).
3.1. Phenotype of Cells Grown from Tissue Explants. To char-
acterise the cells that grow out of explant tissue, cells were
stained with a panel of phenotype markers (Table 1). These
included cytoskeletal proteins (vimentin, SMA, desmin),
RECA, pan-cytokeratin, and the epithelial cell-cell junction
protein E-cadherin. In accordance with the staining char-
acteristics, cells were deﬁned as mesenchymal (vimentin+,
SMA+, desmin+), epithelial (cytokeratin+), or endothelial
(RECA+) cells. At day 7, 66 ± 9% (mean ± S E )o fc e l l s4 Journal of Biomedicine and Biotechnology
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Figure 2: Immunohistochemical staining characteristics of cells 10 days after explanting. Two distinct areas are seen—an inner most area of
cuboidal-shaped cells staining for (a) cytokeratin and (b) E-cadherin (black asterisk) and stellate-shaped cells at the periphery staining for
(c) the myoﬁbroblast marker SMA. Occasional cells at the junction of the two areas stain for SMA (arrow heads). (d) All cells were negative
for the endothelial marker RECA. Remnants of the tissue explant from which cells have propagated can be seen (white asterisk). Scale bar =
50μm.
were vimentin+, 21 ± 8% SMA+, 26 ± 8% desmin+, and
79 ± 5% cytokeratin+. Cells did not express RECA. By day
10, explants typically contained clusters of E-cadherin and
cytokeratin-positive cells, surrounded by a peripheral region
of cells staining for the mesenchymal marker SMA (Figure
2). Accordingly, it was apparent that explants consisted of
epithelial cell outgrowths, with myoﬁbroblasts present at the
periphery. The acquisition of SMA, a myoﬁbroblast marker,
at the periphery of the outgrowths suggests that cells that
previously expressed epithelial markers may be undergoing
transition to a mesenchymal cell type.
3.2. Double Labeling Indicates That Cell Outgrowths from
Explants Undergo Progressive EMT. To determine if the mes-
enchymaland epithelial cellsshown inFigure 2 were autono-
mouscellpopulations orcellsundergoingEMT,immunoﬂu-
orescentdouble labellingwasperformedat3, 10,and 17days
after explanting using red (SMA) and green (cytokeratin)
ﬂuorochromes (Figure 3). Merged ﬂuorescent micrographs
conﬁrmed that at day 3 outgrowths from tissue were
almost exclusively epithelial cells (cytokeratin+/SMA−)w i t h
myoﬁbroblasts (cytokeratin−/SMA+ cells) recognised from
day 10. This was most likely due to EMT as 50 ± 12% (n = 5
explants) of cytokeratin-positive cells costained for SMA at
day 10. By day 17 cultures were all uniformly myoﬁbroblasts,
each with a well-organised SMA cytoskeleton.
3.3. Lectin Staining Indicates That Cell Outgrowths from
Explants Have a Predominantly Proximal Tubular Derivation.
Little is known about the speciﬁc derivation of tubular
epithelial cells during EMT. In attempt to determine the
nephron origin of the cells undergoing EMT, cell explant
outgrowths were labelled for sugar moieties expressed by
various nephron segments. AH is speciﬁc for distal tubule
epithelium, whilst Pha-E and Pha-L are speciﬁc for proximal
tubule epithelium (data not shown). Staining of explants
with biotinylated lectins illustrates that, of those cells that
grow out of explant tissue, the majority are derived from
proximal tubular epithelium (Figure 4) with no cells staining
positive for distal tubular epithelium lectin markers.
4. Discussion
This study has shown that explanting of renal kidney
tissue is a reproducible ex vivo model of EMT. Explanting
methodologies consistently produced a population of cellsJournal of Biomedicine and Biotechnology 5
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Figure 3: Double labeling for the epithelial marker cytokeratin and the myoﬁbroblast marker SMA was used to determine if cell outgrowths
were undergoing EMT. Two-colour immunoﬂuorescence was performed at 3, 10, and 17 days after explanting. By labelling for both SMA
(red) and cytokeratin (green), outgrowths were initially epithelial at day 3. By day 10 cell outgrowths expressed both SMA and cytokeratin
(yellow) indicating that cells were coexpressing epithelial and mesenchymal markers. By day 17, cells had developed a mesenchymal
phenotype, and all stained positive for SMA. Scale bar = 25μm.
displaying the transitional features of EMT. Lectin studies
suggest that the majority of these cells are derived from
proximal tubule segments.
Duringembryogenesis,EMTgivesrisetoanarrayoffully
diﬀerentiated adult cell types derived from pluripotential
cells present in the developing embryo [21]. Accordingly,
EMT in the kidney can be viewed as a reversal of renal em-
bryogenesis where the metanephric mesoderm gives rise to
the majority of nephron segments [22]. In the adult such
transitions have generally been conﬁned to those seen in
wound healing and angiogenesis [21]. An increasing amount
of evidence, however, suggests that cellular plasticity in the
adult has been underestimated. Embryonic EMT can be re-
capitulated during certain adult disease states such as cancer
and ﬁbrosis [13] where dramatic morphological and func-
tional changes are required to allow cells to migrate and in-
vade.
Although the importance of EMT in the kidney has only
been recognised relatively recently, the potential for EMT in
adult cell types has been long known [23]a n dm a yb ea
relatively ubiquitous phenomenon in many labile cell types.
EMT of tubular epithelia is the direct consequence of the
release of a plethora of growth factors and other mediators
in the surrounding environment after injury. These origi-
nate from both resident and inﬁltrating cells [7]. EMT is
facilitated by the sequential loss of epithelial cell adhesion
[24], degradation of basement membrane, de novo SMA ex-
pression, and migration into the interstitial space [21, 25]. In
ﬁbrotic kidney disease, this culminates in increased deposi-
tion of extracellular matrix and a consequent destruction of
renal architecture and loss of function [4, 21].
In vitro experiments that have been used to demonstrate
EMT to date have provided valuable insights into various
mechanisms governing EMT and have highlighted the com-
plexity in bringing about a complete change in cellular phe-
notype and function. However, although they are able to
provide more steadfast evidence of the sequential events
involved, in vitro experiments typically use immortalised cell
lines or isolated cells in which the relationship between the
tubular epithelium and surrounding matrix environment,
one of which is integral to EMT, cannot be studied [13, 14].
Ourworkwasthereforeaimedattakingamorepathophysio-
logically relevant approach to examine the potential of EMT
to occur under ex vivo circumstances.
The explant model described here resembles the sponta-
neous EMT that has been shown to occur with other tissue
explants, in particular the cornea [26]. Initial outgrowths are
cytokeratinpositivewithcellsthenchangingtheirphenotype
as they grow outward from the tissue fragments. The fact
that only peripheral cells undergo EMT is consistent with6 Journal of Biomedicine and Biotechnology
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Figure 4: Lectin staining characteristics of cell outgrowths, 10 days after explanting. The majority of cells stain for Pha-E and Pha-L,
lectins speciﬁc for the proximal tubular epithelium. (a) Arachis hypogaea (AH); (b) Bandeiraea simplicifolia I( B S L - I ) ;( c )Phaseolus vulgaris
erythroagglutinin (Pha-E); (d) Phaseolus vulgaris leukoagglutinin (Pha-L). Scale bar = 25μm.
Masszi et al.’s postulate that injury or absence of intracellular
contactisakeyprimingfactorforEMT[27,28].Asindicated
by our results, cells subsequently lose their staining for
cytokeratin and express SMA only. To conﬁrm that these
cells were not autonomous cell populations but rather that
thesecellswereonceepithelialinphenotype,doublelabelling
was used. This demonstrated that 50% of cells in the pop-
ulation coexpressed SMA and cytokeratin. Although this
study only provides a snapshot of EMT at one given time
point, it supports previous evidence of EMT’s important
contribution to renal ﬁbrogenesis [7].
S e v e r a lt u b u l es e g m e n t sh a v eb e e ns h o w nt og i v er i s et o
myoﬁbroblasts [29–32], with our study supporting a prox-
imal tubule origin for myoﬁbroblasts. However, given that
we speciﬁcally excised renal cortex for explanting, the contri-
bution of other nephron segments to EMT cannot clearly be
determined.
In conclusion, our study highlights that explanting of
normalratrenaltissueisausefulexvivomodeltostudyEMT.
Given the signiﬁcance of EMT in the pathogenesis of end-
stage renal disease, this model is a valuable tool for the study
of this important process.
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